Knee Osteoarthritis Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Knee Osteoarthritis Market is segmented By Knee Osteoarthritis Treatment (Pharmacological Management, Non-Pharmacological Management, Surgery), By Disease Type (Primary Osteoarthritis, Secondary Osteoarthritis), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Competitive overview of Knee Osteoarthritis Market
The major players operating in the knee osteoarthritis market include Sanofi/Genzyme, Bioventus, Anika Therapeutics, Taiwan Liposome Company (TLC599), Centrexion Therapeutics (CNTX-4975), Biosplice Therapeutics (Lorecivivint), Noven Pharmaceuticals (HP-5000) and Kolon TissueGene (Invossa TG-C).
Knee Osteoarthritis Market Leaders
- Anika Therapeutics
- Bioventus
- Sanofi/Genzyme
- Taiwan Liposome Company (TLC599)
- Centrexion Therapeutics (CNTX-4975)
*Disclaimer: Major players are listed in no particular order.
Knee Osteoarthritis Market - Competitive Rivalry, 2023
Knee Osteoarthritis Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights